
Yaohai Bio-Pharma, founded in 2010, is a premier CRDMO specializing in microbial expression systems. We focus on the development and manufacturing of recombinant proteins, plasmids, nano-bodies, vaccines, mRNA, and circRNA. We operate as a comprehensive contract pharmaceutical company, providing integrated CRO/CDMO/MAH services across the entire biologics lifecycle.

Integer quam lacinia nibh erat nam. Lobortis nec ullamcorper tincidunt ante feugiat curabitur dui nulla tempus luctus sapien. Sollicitudin ullamcorper iaculis ipsum dui lorem nostra velit parturient semper penatibus.
As a global crdmo company, Yaohai Bio-Pharma leverages our ISO-certified and EU QP-audited platform to streamline your global regulatory pathways.

Specializing in advanced process development and diverse biologics manufacturing, Yaohai Bio-Pharma delivers high-quality, GMP-compliant microbial CRDMO solutions worldwide.
Yaohai Bio-Pharma operates as a premier biologics CDMO platform, delivering tailored microbial solutions that streamline your drug development lifecycle with rigid global compliance.
A robust track record of over 200 successful projects spanning preclinical studies to Phase I/II/III clinical trials, featuring verified US–China dual submissions and Australian regulatory filings.
A robust, GMP-aligned quality system with standardized SOPs, fully compliant with global regulatory guidelines as a leading crdmo company.
Powered by industry-leading scientists and cross-functional experts, our team delivers technical precision to accelerate your microbial CRDMO projects.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Ipsum pede habitant letius efficitur condimentum penatibus potenti tortor morbi
Ipsum pede habitant letius efficitur condimentum penatibus potenti tortor morbi
Ipsum pede habitant letius efficitur condimentum penatibus potenti tortor morbi



